Vascular access surveillance: an ongoing controversy

被引:80
|
作者
Paulson, William D. [2 ,3 ]
Moist, Louise [4 ]
Lok, Charmaine E. [1 ,5 ]
机构
[1] Toronto Gen Hosp, Dept Med, Div Nephrol, Toronto, ON M5G 2C4, Canada
[2] Georgia Hlth Sci Univ, Dept Med, Charlie Norwood VA Med Ctr, Augusta, GA USA
[3] Georgia Hlth Sci Univ, Dept Med, Nephrol Sect, Augusta, GA USA
[4] Univ Western Ontario, Div Nephrol, London, ON, Canada
[5] Univ Toronto, Toronto, ON, Canada
关键词
arteriovenous fistula; arteriovenous graft; clinical practice guidelines; vascular access; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; VENOUS NEOINTIMAL HYPERPLASIA; HEMODIALYSIS GRAFT THROMBOSIS; BLOOD-FLOW; ARTERIOVENOUS-FISTULAS; PHYSICAL-EXAMINATION; LUMINAL DIAMETERS; SYNTHETIC GRAFTS; CONTROLLED-TRIAL; EARLY FAILURE;
D O I
10.1038/ki.2011.337
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hemodialysis vascular access surveillance continues to be widely recommended despite ongoing controversy as to its benefit in prolonging access patency compared with clinical monitoring alone. The most common screening tests are access blood flow and dialysis venous pressure measurements. When surveillance test results cross a predetermined threshold, accesses are referred for intervention with correction of stenosis to reduce future thrombosis and prolong access survival. Current surveillance strategies have four components: (1) underlying condition; (2) screening test; (3) intervention; and (4) outcomes. However, limitations exist within each component that may prevent achieving the desired outcomes. This review discusses these limitations and their consequences. To date, randomized controlled trials have not consistently shown that surveillance improves outcomes in grafts, and there is limited evidence that surveillance reduces thrombosis without prolonging the life of native fistulae. In conclusion, current evidence does not support the concept that all accesses should undergo routine surveillance with intervention. Kidney International (2012) 81, 132-142; doi:10.1038/ki.2011.337; published online 5 October 2011
引用
收藏
页码:132 / 142
页数:11
相关论文
共 50 条
  • [21] Vascular access in Spain:: Distribution, morbidity and surveillance systems
    Hernández, JAR
    Pedret, JL
    Piera, L
    NEFROLOGIA, 2001, 21 (01): : 45 - 51
  • [22] Why vascular access trials on flow surveillance failed
    Krivitski, Nikolai
    JOURNAL OF VASCULAR ACCESS, 2014, 15 : S15 - S19
  • [23] The role of regular surveillance on maintenance of patency of vascular access
    Khairy, Ahmed
    Rashed, Ahmed M.
    Shahat, Mohamed
    Ali, Haitham
    EGYPTIAN JOURNAL OF SURGERY, 2022, 41 (03): : 1002 - 1008
  • [24] Vascular access surveillance: Evaluation of combining dynamic venous pressure and vascular access blood flow measurements
    Hoeben, H
    Abu-Alfa, AK
    Reilly, RF
    Aruny, JE
    Bouman, K
    Perazella, MA
    AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (06) : 403 - 408
  • [25] Inhalation of aerosols by children:: an ongoing controversy
    Schöni, MH
    SWISS MEDICAL WEEKLY, 2004, 134 (13-14) : 173 - 174
  • [26] Congenital lung malformations: an ongoing controversy
    Peters, R. T.
    Burge, D. M.
    Marven, S. S.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2013, 95 (02) : 144 - 147
  • [27] The Ongoing Controversy: Crystalloids Versus Colloids
    Pierce, Janet D.
    Shen, Qiuhua
    Thimmesch, Amanda
    JOURNAL OF INFUSION NURSING, 2016, 39 (01) : 40 - 44
  • [28] AN ONGOING DOWNTOWN OFFICE BUILDING CONTROVERSY
    LOEWENSTEIN, LK
    REAL ESTATE REVIEW, 1980, 10 (03): : 94 - &
  • [29] Binswanger's disease: An ongoing controversy
    Hurley, RA
    Tomimoto, H
    Akiguchi, I
    Fisher, RE
    Taber, KH
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2000, 12 (03) : 301 - 304
  • [30] Clopidogrel–PPI interaction, an ongoing controversy
    Paul A. Gurbel
    Udaya S. Tantry
    Nature Reviews Cardiology, 2011, 8 : 7 - 8